loading
前日終値:
$3.44
開ける:
$3.44
24時間の取引高:
82,043
Relative Volume:
0.08
時価総額:
$649.41M
収益:
$12.99M
当期純損益:
$-74.39M
株価収益率:
-7.50
EPS:
-0.46
ネットキャッシュフロー:
$-78.92M
1週間 パフォーマンス:
-5.10%
1か月 パフォーマンス:
-15.36%
6か月 パフォーマンス:
+7.32%
1年 パフォーマンス:
+88.25%
1日の値動き範囲:
Value
$3.428
$3.5099
1週間の範囲:
Value
$3.42
$3.68
52週間の値動き範囲:
Value
$1.79
$4.725

Arbutus Biopharma Corp Stock (ABUS) Company Profile

Name
名前
Arbutus Biopharma Corp
Name
セクター
Healthcare (1195)
Name
電話
604-419-3200
Name
住所
701 VETERANS CIRCLE, WARMINSTER, PA
Name
職員
73
Name
Twitter
@arbutusbio
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
ABUS's Discussions on Twitter

ABUS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABUS 3.445 649.41M 12.99M -74.39M -78.92M -0.46
VRTX 445.81 115.74B 10.63B -479.80M -1.35B 13.33
REGN 735.95 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 584.00 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 247.73 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.25 24.49B 3.30B -501.07M 1.03B 11.54

Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-02-02 アップグレード Jefferies Hold → Buy
2021-02-25 開始されました Jefferies Hold
2020-12-17 開始されました H.C. Wainwright Buy
2020-07-27 再開されました JMP Securities Mkt Outperform
2020-07-24 ダウングレード Robert W. Baird Outperform → Neutral
2020-05-19 アップグレード Wedbush Neutral → Outperform
2020-03-06 アップグレード Chardan Capital Markets Neutral → Buy
2020-02-20 開始されました Robert W. Baird Outperform
2020-02-05 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2019-10-07 繰り返されました B. Riley FBR Buy
2019-10-04 ダウングレード Chardan Capital Markets Buy → Neutral
2018-10-16 アップグレード B. Riley FBR Neutral → Buy
2018-10-15 アップグレード Wedbush Underperform → Neutral
2018-10-12 繰り返されました Chardan Capital Markets Buy
2018-07-06 ダウングレード B. Riley FBR, Inc. Buy → Neutral
2018-03-19 再開されました Chardan Capital Markets Buy
2018-03-19 ダウングレード Wedbush Outperform → Neutral
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-04-04 アップグレード Chardan Capital Markets Neutral → Buy
2017-02-01 繰り返されました Wedbush Outperform
2016-12-13 ダウングレード Chardan Capital Markets Buy → Neutral
2016-11-30 アップグレード Chardan Capital Markets Neutral → Buy
すべてを表示

Arbutus Biopharma Corp (ABUS) 最新ニュース

pulisher
Nov 20, 2024

Arbutus Biopharma (NASDAQ:ABUS) Earns "Buy" Rating from Chardan Capital - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

HC Wainwright Reiterates Buy Rating for Arbutus Biopharma (NASDAQ:ABUS) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment - MyChesCo

Nov 17, 2024
pulisher
Nov 17, 2024

Arbutus Biopharma Announces Positive Data from Clinical Trials at AASLD – The Liver Meeting® 2024 - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Promising New Data from Hepatitis B Trial by Arbutus and Barinthus - MyChesCo

Nov 17, 2024
pulisher
Nov 17, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Down 16.0% in October - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results - MyChesCo

Nov 16, 2024
pulisher
Nov 16, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Update - MarketBeat

Nov 16, 2024
pulisher
Nov 14, 2024

Two Seas Capital LP Adjusts Stake in Arbutus Biopharma Corp - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Arbutus to Present at Jefferies London Healthcare Conference - Yahoo Finance

Nov 14, 2024
pulisher
Nov 12, 2024

Creative Planning Raises Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

HC Wainwright Has Negative Forecast for ABUS FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Expects Weaker Earnings for Arbutus Biopharma - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

HC Wainwright Reaffirms “Buy” Rating for Arbutus Biopharma (NASDAQ:ABUS) - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Arbutus Biopharma 8-K Filing: Financial Results and Corporate Presentation Update - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

JMP Securities Increases Arbutus Biopharma (NASDAQ:ABUS) Price Target to $5.00 - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

HC Wainwright Reaffirms Buy Rating for Arbutus Biopharma (NASDAQ:ABUS) - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

Arbutus Fades on Q4 Results - Baystreet.ca

Nov 06, 2024
pulisher
Nov 06, 2024

Arbutus Biopharma earnings missed, revenue fell short of estimates - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Arbutus Biopharma Corp Q3 2024 Earnings: EPS Loss of $0.10 Meets Estimates, Revenue Falls Short at $1.3 Million - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Arbutus: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 06, 2024
pulisher
Nov 06, 2024

Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Nov 06, 2024
pulisher
Oct 30, 2024

Arbutus Biopharma (ABUS) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024
pulisher
Oct 23, 2024

Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

SG Americas Securities LLC Acquires New Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Oct 23, 2024
pulisher
Oct 16, 2024

Arbutus Biopharma Target of Unusually High Options Trading (NASDAQ:ABUS) - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Arbutus Biopharma Corp (ABUS) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 16, 2024
pulisher
Oct 15, 2024

Arbutus Biopharma (NASDAQ:ABUS) Trading Up 5.7%Still a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLDThe Liver Meeting® 2024 - Yahoo Finance

Oct 15, 2024
pulisher
Oct 14, 2024

Arbutus Biopharma announces officer retirement terms By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

Arbutus Biopharma announces officer retirement terms - Investing.com India

Oct 14, 2024
pulisher
Oct 11, 2024

Arbutus Biopharma CSO Michael Sofia Announces Retirement Plans - TipRanks

Oct 11, 2024
pulisher
Oct 11, 2024

Examining Arbutus Biopharma Corp (ABUS) stock is warranted - US Post News

Oct 11, 2024
pulisher
Oct 10, 2024

Arbutus Biopharma Corp [ABUS] stock for 32,637 USD was sold by MANCHESTER KEITH S - Knox Daily

Oct 10, 2024
pulisher
Oct 08, 2024

Balance Sheet Dive: Arbutus Biopharma Corp (ABUS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 08, 2024
pulisher
Oct 07, 2024

Top investors say Arbutus Biopharma Corp (ABUS) ticks everything they need - SETE News

Oct 07, 2024
pulisher
Oct 03, 2024

XTX Topco Ltd Buys Shares of 17,038 Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Oct 03, 2024
pulisher
Oct 02, 2024

Jefferies Upgrades Arbutus Biopharma Corp (ABUS) to a Buy from a Hold - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

How to interpret Arbutus Biopharma Corp (ABUS)’s stock chart patterns - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Taking on analysts’ expectations and winning: Arbutus Biopharma Corp (ABUS) - SETE News

Oct 01, 2024
pulisher
Oct 01, 2024

Arbutus Biopharma Corp (ABUS)’s Day in Review: Closing at 3.85, Up by 0.52 - The Dwinnex

Oct 01, 2024
pulisher
Oct 01, 2024

Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference - Yahoo Finance

Oct 01, 2024
pulisher
Sep 29, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Up 8.3% in September - MarketBeat

Sep 29, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Arbutus Biopharma stock navigates legal wins and pipeline focus - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 2.8% - MarketBeat

Sep 27, 2024

Arbutus Biopharma Corp (ABUS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):